Professor, Psychiatry, University of Texas Southwestern Medical Center, Southwestern Medical School
Psychiatry
Dr. Graham J. Emslie, MD
|
|
Give Review
Graham Emslie works in the field of Psychiatry. He received 3 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Graham J. Emslie has written publications. He has 64 publications published with PubMed. The lastest paper is: 'Cortical inhibitory and excitatory correlates of depression severity in children and adolescents.'
Publications
- Cortical inhibitory and excitatory correlates of depression severity in children and adolescents.
- A Double-Blind Efficacy and Safety Study of Duloxetine Flexible Dosing in Children and Adolescents with Major Depressive Disorder.
- A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder.
- The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.
- Depressed Adolescents Treated with Exercise (DATE): A pilot randomized controlled trial to test feasibility and establish preliminary effect sizes.
- Impact of treatments for depression on comorbid Anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depr...
- The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression.
- Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder.
- Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
- Depression Pharmacotherapy in an Adolescent with Hodgkin's Lymphoma.
- A preliminary investigation of corpus callosum and anterior commissure aberrations in aggressive youth with bipolar disorders.
- Insomnia Moderates Outcome of Serotonin-Selective Reuptake Inhibitor Treatment in Depressed Youth.
- Increased Cortical Excitability with Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation in Adolescents with Treatment-Resistant Major Depressive Di...
- An Open-Label Safety and Pharmacokinetics Study of Duloxetine in Pediatric Patients with Major Depression.
- Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study.
- Predictors of treatment response in adolescent depression.
- Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study.
- Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents.
- Psychometric properties of the Children's Depression Rating Scale-Revised in adolescents.
- A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial ...
- Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder.
- Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
- Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: preliminary findings.
- Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder.
- DATE: Depressed adolescents treated with exercise: Study rationale and design for a pilot study.
- Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.
- Combination of cognitive behavioral therapy and sertraline is more effective than monotherapy for pediatric Anxiety disorders.
- Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
- Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response.
- Assessment of safety and long-term outcomes of initial treatment with placebo in TADS.
- Remission and recovery in the Treatment for Adolescents with Depression Study (TADS): acute and long-term outcomes.
- Understanding placebo response in pediatric depression trials.
- Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder.
- Pediatric Anxiety--underrecognized and undertreated.
- Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
- Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth.
- Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
- Maternal depressive symptoms in pediatric major depressive disorder: relationship to acute treatment outcome.
- Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
- Improving outcome in pediatric depression.
- Psychopharmacological treatment for very young children: contexts and guidelines.
- Antidepressant management in the context of suicidal ideation.
- A pilot study of an electronic, adolescent version of the quick inventory of depressive symptomatology.
- A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children.
- Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.
- Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder.
- Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine?
- Relapse and recurrence in pediatric depression.
- A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.
- Cognitions and depressive symptoms among ethnic minority adolescents.
- Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
- Validation of the Mood Disorder Questionnaire for bipolar disorders in adolescents.
- Sex and age differences in sleep macroarchitecture in childhood and adolescent depression.
- Effect of structured interviews on evaluation time in pediatric community mental health settings.
- Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or Anxiety symptoms.
- Depressive symptoms predict hospitalization for adolescents with type 1 diabetes mellitus.
- Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
- Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.
- A cross-cultural investigation of cognitions and depressive symptoms in adolescents.
- Predictors of response to treatment in children and adolescents with mood disorders.
- A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD.
- Citalopram in children and adolescents with depression or Anxiety.
- Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial.
Conditions Treated
- Anxiety
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Stanford University -
University of Rochester -
University of Aberdeen Faculty of Medicine
Hospital
-
University of Texas Southwestern Medical Center -
Children's Health System of Texas
Helpful Reviews
Similar Doctors
|
|
Dr. Sabrina A. Browne, MD |
|
|
Dr. Barry J. Fenton, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leon D. Rosenthal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lacy L. Edmundson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Madeline W. Harford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark P. Unterberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Talmadge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olayemi A. Faniran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hisham M. Ibrahim, MD |
|
|
Dr. Andrea Kim, MD |
|
|
Dr. Robert C. Schwartz Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Djillali Boudjenah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abbie M. Ewell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carmen E. Llauger-Mier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zakaria A. Zayour, MD |
|
|
Dr. Rosemary E. Wright, DO |
|
|
Dr. Gus Q. Zhang, MD
This Doctor is OpenDoctor Recommended.
|